What sounds like a dream of the future has already been the subject of research for a few years: simply printing out tissue and organs.
Now scientists have further refined the technology and are able to produce various tissue types.
The recent organ transplant scandals have only made the problem worse. According to the German Organ Transplantation Foundation (DSO), the number of organ donors in the first half of 2013 has declined more than 18 percent in comparison to the same period the previous year. At the same time, one can assume that the demand in the next years will continuously rise, because we continue to age and field of transplantation medicine is continuously advancing. Many critical illnesses can already be successfully treated today by replacing cells, tissue, or organs. Government, industry, and the research establishment have therefore been working hard for some time to improve methods and procedures for artificially producing tissue. This is how the gap in supply is supposed to be closed.
Bio-ink made from living cells
One technology might assume a decisive role in this effort, one that we are all familiar with from the office, and that most of us would certainly not immediately connect with the production of artificial tissue: the inkjet printer. Scientists of the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart have succeeded in developing suitable bio-inks for this printing technology. The transparent liquids consist of components from the natural tissue matrix and living cells. The substance is based on a well known biological material: gelatin. Gelatin is derived from collagen, the main constituent of native tissue. The researchers have chemically modified the gelling behavior of the gelatin to adapt the biological molecules for printing. Instead of gelling like unmodified gelatin, the bio-inks remain fluid during printing. Only after they are irradiated with UV light, they crosslink and cure to form hydrogels.
These are polymers containing a huge amount of water (just like native tissue), but which are stable in aqueous environments and when being warmed up to physiological 37°C. The researchers can control the chemical modification of the biological molecules so that the resulting gels have differing strengths and swelling characteristics. The properties of natural tissue can therefore be imitated – from solid cartilage to soft adipose tissue.
In Stuttgart synthetic raw materials are printed as well that can serve as substitutes for the extracellular matrix. For example a system that cures to a hydrogel devoid of by-products, and can be immediately populated with genuine cells. “We are concentrating at the moment on the ‘natural’ variant. That way we remain very close to the original material. Even if the potential for synthetic hydrogels is big, we still need to learn a fair amount about the interactions between the artificial substances and cells or natural tissue. Our biomolecule-based variants provide the cells with a natural environment instead, and therefore can promote the self-organizing behavior of the printed cells to form a functional tissue model,” explains Dr. Kirsten Borchers in describing the approach at IGB.
The printers at the labs in Stuttgart have a lot in common with conventional office printers: the ink reservoirs and jets are all the same. The differences are discovered only under close inspection. For example, the heater on the ink container with which the right temperature of the bio-inks is set. The number of jets and tanks is smaller than in the office counterpart as well. “We would like to increase the number of these in cooperation with industry and other Fraunhofer Institutes in order to simultaneously print using various inks with different cells and matrices. This way we can come closer to replicating complex structures and different types of tissue,” says Borchers.
Go deeper with Bing News on:
Printing tissues and organs
- 3D printing, biology research make the journey back to Earth aboard SpaceX's Dragonon April 7, 2020 at 12:53 pm
Under Earth's gravity, an initial scaffolding, or support structure, is necessary to form the desired shape of the tissue. The BioFabrication Facility (BFF) attempts to take the first steps toward ...
- Scientists Use AI To Create Transparent 3D Images of Organson April 7, 2020 at 11:44 am
While the process of tissue clearing—whereby an organ is made transparent through the use of special dyes that change ... And how soon do you think we’ll be 3D printing livers, hearts, and eyeballs?
- 3D-printed scaffold engineered to grow complex tissueson April 7, 2020 at 9:43 am
Advances in 3D printing techniques have led to hope for improvements in regenerative medicine. This area of research aims to use stem cells and other technologies—such as engineered biomaterials—to ...
- Watch live Today! SpaceX Dragon cargo ship to leave International Space Stationon April 7, 2020 at 5:16 am
The BioFabrication Facility (BFF) attempts to take the first steps toward the printing of human organs and tissues in microgravity. The facility may also help maintain the health of crews on deep ...
- 3D Bioprinting Market Study with Current and Upcoming Trends 2022on April 7, 2020 at 12:53 am
The global 3D bioprinting market is projected to reach a value of 792 5 million in 2022 witnessing a CAGR of 35 9 during the forecast period 2016 2022 The market is registering growth due to the high ...
Go deeper with Google Headlines on:
Printing tissues and organs
Go deeper with Bing News on:
- A 'cardiac patch with bioink' developed to repair hearton April 2, 2020 at 1:08 pm
Medical researchers have developed an 'in vivo priming' with heart-derived bioink. Using engineered stem cells and 3D bioprinting technology, they began developing medicines for cardiovascular ...
- CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2019on April 2, 2020 at 2:30 am
CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced financial results for the full year ended December 31, 2019 and provided an update on the Company's business ...
- Viscient Biosciences Will Bioprint 3D Lung Tissue to Aid Pandemic Research, and Viscient Founder Calls for Pause in Organovo Merger Attempton March 31, 2020 at 12:29 pm
Viscient will turn its attention to 3D bioprinting lung tissue for infectivity research to assist global efforts to combat SARS-CoV-2, the novel coronavirus that causes COVID-19 Organovo failed to ...
- New 3D bioprinting technologies to create cardiovascular tissueon March 31, 2020 at 8:16 am
This need is driving the development of cardiovascular 3D bioprinting technologies, which make use of 3D printing-like techniques to combine cells and biomaterials to fabricate biomimetic structures ...
- Global 3D Bioprinting Market 2020-2026 Poietis, GeSiM, Exone, Stratasys, Advanced BioMatrix, Ricoh Company Ltdon March 31, 2020 at 1:51 am
An exclusive research report on the 3D Bioprinting Market 2020-2026 has been fabricated through the detailed analysis of the 3D Bioprinting market dynamics along with some significant aspects of the ...